Last 17,700 KRW
Change Today -100.00 / -0.56%
Volume 185.4K
052260 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 2:26 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

bioland ltd (052260) Snapshot

Open
17,450
Previous Close
17,800
Day High
17,800
Day Low
17,250
52 Week High
07/15/14 - 18,900
52 Week Low
11/19/13 - 9,710
Market Cap
265.5B
Average Volume 10 Days
349.3K
EPS TTM
--
Shares Outstanding
15.0M
EX-Date
12/27/13
P/E TM
--
Dividend
200.00
Dividend Yield
1.13%
Current Stock Chart for BIOLAND LTD (052260)

Related News

No related news articles were found.

bioland ltd (052260) Related Businessweek News

No Related Businessweek News Found

bioland ltd (052260) Details

Bioland Co., Ltd. engages in the manufacture and sale of raw materials for cosmetics and pharmaceuticals primarily in Korea. The company offers botanical extracts and synthetic products, such as anti-inflammatory, whitening, anti-aging, anti-irritation, moisturizing, and hair care products for cosmeceutical industries; and phellodendron, gardenia florida, zanthoxylum, ampelopsis, artemisia absinthium, and uncaria gambier extracts for pharmaceutical industries. It also provides netraceuticals comprising red ginseng extract powders, jeju seaweed powders, puer tea, soluvone, netra HA and netra HAF, oligo chitosan, green tea extracts, SCS, cate queen, bio-peptides, glucosamine, lsoflavone, stevion, casein phosphopeptide, and edible enzymes. In addition, the company offers tissue engineering products, including biological wound dressings, such as AmniSite-Skin, AmniSite-Cornea, and AmniSite-BA; and collagen products. Further, it provides diagnostic kits comprising rapid kits, such as hepatitis, infectious diseases, cancer marker, drug of abuse, fertility hormones, veterinary applications, parasitic diseases, and urine analysis; serological kits; ELISA kits; and Q-rapid systems. Bioland Co., Ltd. was founded in 1995 and is headquartered in Cheonan, South Korea.

Founded in 1995

bioland ltd (052260) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bioland ltd (052260) Key Developments

Bioland Co., Ltd., Annual General Meeting, Mar 14, 2014

Bioland Co., Ltd., Annual General Meeting, Mar 14, 2014., at 11:30 Korea Standard Time. Location: Songjeongri two way byeongcheonmyeon 59 (Biotechnology Research Institute 2nd Floor). Agenda: To consider the article 19 group financial statements 2013; to consider the election of directors; to consider the appointment of outside directors; to consider the appointment of corporate director; and to consider the approval of director remuneration.

Bioland Co., Ltd., Annual General Meeting, Mar 22, 2013

Bioland Co., Ltd., Annual General Meeting, Mar 22, 2013., at 11:00 Korea Standard Time. Location: Cheonan-dong, Nam-gu, byeongcheonmyeon Songjeong-ri road 5. Agenda: To consider 2012 financial statements (Included) approve the consolidated financial statements; to consider the appointment of outside Directors; to Approve directors' remuneration limit; to approve the audit fees limit; to consider the date of Board of Directors' resolution (Decision Date) 2013-02-25; and to consider other references concerning investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
052260:KS 17,700.00 KRW -100.00

052260 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 052260.
View Industry Companies
 

Industry Analysis

052260

Industry Average

Valuation 052260 Industry Range
Price/Earnings 28.9x
Price/Sales 3.8x
Price/Book 2.6x
Price/Cash Flow 26.8x
TEV/Sales 3.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOLAND LTD, please visit www.biolandkorea.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.